Viralkumar M. Patel
ORCID:0000-0003-3385-0557
发表论文 20 篇 · 总被引 539 次 · h-index 9
代表论文
- Comparison of Acalabrutinib, A Selective Bruton Tyrosine Kinase Inhibitor, with Ibrutinib in Chronic Lymphocytic Leukemia Cells (2016 · Clinical Cancer Research · 被引 148)
- Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. (1991 · Journal of Clinical Investigation · 被引 141)
- Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199) (2016 · Leukemia · 被引 68)
- Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy (2017 · Leukemia · 被引 45)
- Expression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cells (2014 · Blood · 被引 38)
- Decrease in total protein level of Bruton’s tyrosine kinase during ibrutinib therapy in chronic lymphocytic leukemia lymphocytes (2016 · Leukemia · 被引 35)